Kerrisdale Capital Recent News
Mirati Dives As Short Seller Says Key Pipeline Assets Doomed
Spruce Point, Kerrisdale Talk Bearish Bets: 'You Have To Work Harder To Understand The Short'
How This Investor Exposed Fraudulent Chinese Companies To The SEC
Kerrisdale Short iRhythm Technologies, Claims Company Is Abusing Reimbursement Process
Kerrisdale: Qualcomm Ruling Could Cut 'Stock Price In Half'
Kerrisdale Has A New Favorite Long: Sea
Kerrisdale Goes Long Intelsat, SES: 'Headed To The Moon'
Kerrisdale Short Report Says St. Joe's Real Estate Plan 'Pure Fantasy'
Kerrisdale Says Suspicious Business Model Makes QuinStreet A 'Dead End,' Company Says Claims Are 'Demonstrably Wrong'
Proteostasis Tumbles 25% After Short Seller Calls Leading Drug Candidate 'A Dud'
Adamas Pharma's Gocovri Will Achieve 'Blockbuster' Status, Says Kerrisdale
Straight Path Communications Buyout Blindsides Short Sellers
Northern Dynasty Responds To Kerrisdale's 'Short And Distort Campaign'
Kerrisdale Capital: Northern Dynasty Stock 'Is A Zero'
Straight Path Faces 70% Downside, Kerrisdale Still Says Market Overreacted To FCC Settlement
First Majestic Silver Has 80% Downside: Kerrisdale's Latest Short Report
Chatrooms Run Amok With False Information And Possible Efforts Of Stock Manipulation
Kerrisdale's Latest: Dish Network Improperly Deducting $1 Billion In Taxes
Kerrisdale Capital Attacks Dish Network In New Short Thesis
Death Of Golf As An Investment? Kerrisdale Capital Shorts ClubCorp, Sees 80% Downside
Kerrisdale Capital Short Thesis On Sage Therapeutics: Lead Drug 'Likely To Fail' In Phase 3
Kerrisdale Short Zafgen, Says Beloranib Has 'No Reasonable Chance' Of FDA Approval And Recent Bullishness Is 'Misplaced'
Kerrisdale Capital Sees 93% Downside To Straight Path Stock